Investor Relations

CBI Press Releases - 2002-2006

August 08, 2006 Commonwealth Biotechnologies, Inc. Reports Financial Results Through June 2006

July 26, 2006 Commonwealth Biotechnologies, Inc. Signs Term Sheet to Acquire Mimotopes Pty Ltd

July 17, 2006 Commonwealth Biotechnologies, Inc. and PharmAust, Limited. Launch Strategic Alliance Agreement

June 26, 2006 Commonwealth Biotechnologies, Inc. Director Plans Sale of Stock - Personal Situation Requires Asset Liquidation

May 30, 2006 Commonwealth Biotechnologies, Inc. to Present at the Wall Street Analyst Forum

May 25, 2006 Commonwealth Biotechnologies, Inc. to Present at the Wall Street Analyst Forum

May 25, 2006 Commonwealth Biotechnologies, Inc. Announces Appointment of Senior Vice President, Sales, Marketing, and Business Development

May 04, 2006 Commonwealth Biotechnologies, Inc. Reports Financial Results for the First Quarter of 2006

February 22, 2006 Commonwealth Biotechnologies, Inc. and the Center for Functional Genomics Sign Strategic Alliance Agreement

February 08, 2006 2005 Revenues for Commonwealth Biotechnologies, Inc. Reach $ 7.8 Million

January 05, 2006 Commonwealth Biotechnologies, Inc. and Prism Pharmaceuticals, Inc., Enter into License Agreement to Develop Helix-Based Peptide Technologies

December 05, 2005 Commonwealth Biotechnologies, Inc. and Intertek ASG Launch Global Marketing Agreement - Companies will Co-Promote Services to the Life Sciences Industry with International Focus

November 29, 2005 NYSSA Presents 9th Annual Biotech/Specialty Pharma Conference

November 29, 2005 Commonwealth Biotechnologies, Inc. to Present at the New York Society of Security Analysts - Company seeks improved analyst coverage. Newsletter directed at clients and investors also announced

October 27, 2005 Year-to-Date Revenue through the Third Quarter for Commonwealth Biotechnologies Inc Exceeds 2004 Annual Revenue

August 08, 2005 Commonwealth Biotechnologies, Inc. Posts Record 2Q Revenue - Second Quarter Net Income of $151,000 Cuts Year-to-Date Loss; Signs New Contracts for the 3rd and 4th Quarters

May 05, 2005 Commonwealth Biotechnologies, Inc. Announces First Quarter Results - Net Loss Attributed Primarily to Delays in Contract Start-Up and Temporary Suspension of Activities in the BSL 3 Suite

April 28, 2005 Delayed Contract Work to Begin at Commonwealth Biotechnologies, Inc. - Work delayed Since 3Q 2004 to begin in May, 2005

April 20, 2005 Commonwealth Biotechnologies, Inc. Announces New Contract Signings - Work to begin in the Second and Third Quarters of 2005

March 22, 2005 Commonwealth Biotechnologies, Inc. Completes Internal Review of Procedures - Source of Positive Test Sample May Never be Known with Certainty

March 10, 2005 Commonwealth Biotechnologies, Inc. Announces Contract Signings - Expands Work-Load at CBI in Support of Vaccine Development

February 04, 2005 Commonwealth Biotechnologies, Inc. Posts Record 2004 Revenues - Company Marks First Full Year of Net Adjusted Operating Profitability Since the Company’s Initial Public Offering, Before One-Time Items

January 17, 2005 Commonwealth Biotechnologies, Inc. Announces Contract Signings - Includes First Major Contract for new FIL Division

December 20, 2004 Commonwealth Biotechnologies Completes Acquisition of Fairfax Identity Labs  (Visit Fairfax Identity Labs)

November 23, 2004 Commonwealth Biotechnologies Acquires Leading DNA Profiling Company - Fairfax Identity Labs

November 15, 2004 Commonwealth Biotechnologies, Inc. Retires Industrial Revenue Bonds Used to Build Its Facility

November 1, 2004 CBI Posts Record Revenues & Profitability Through the Third Quarter

September 30, 2004 Commonwealth Biotechnologies, Inc. to Participate in NCI Sponsor Clinical Trial - Conduct of Molecular Screening Assays for Early Detection of Bladder Cancer Genetic Markers

September 29, 2004 Commonwealth Biotechnologies, Inc. Adds New Contracts; Announces Renewal of 5 Year Development Contract with IITRI - $ 1.5 Million in New Contracts brings 2004 Signing Totals to over $ 8 million

September 07, 2004 Commonwealth Biotechnologies, Inc. Teams with Fisher Scientific to Sell its Services and Products - Distribution and Service Agreement Puts Fisher Sales Force to Work for CBI As seen on USA Today

August 26, 2004 Commonwealth Biotechnologies, Inc. Names New Director - Dr. Gerald Krueger has Extensive Military Research Experience

August 12, 2004 Commonwealth Biotechnologies, Inc. Announces $ 2.0 Million of New Business Contracts - Focus in Core Competency Areas

July 29, 2004 Commonwealth Biotechnologies, Inc. Posts Profitable Second Quarter - Fourth Consecutive Quarter of Net Income

July 6, 2004 Commonwealth Biotechnologies Demands Halting of Trading of its Common Stock on the Berlin-Bremen Stock Exchange

July 1, 2004 New Initiatives at Commonwealth Biotechnologies, Inc. - Biosafety Lab Expansion, Patent Issuance; New Product Line

July 1, 2004 New Contracts at Commonwealth Biotechnologies, Inc. - Focus is in Bio Defense Related Work

May 27, 2004 Commonwealth Biotechnologies, Inc. Closes $2.5M Private Placement - Investment Expected to Enhance Company’s Bio-Defense Capabilities and Marketing Efforts

May 11, 2004 Commonwealth Biotechnologies, Inc. Announces Contract Signings Company Pipeline Continues to Increase

April 26, 2004 Commonwealth Biotechnologies, Inc. Retains Jesup and Lamont Securities Corp to Identify Investment Capital

March 31, 2004 Auditors Remove “Going Concern” Consideration for Commonwealth Biotechnologies, Inc. - Company’s Financial Condition Shows Dramatic Improvement

March 30, 2004 Commonwealth Biotechnologies, Inc. Launches New Biodefense Business Initiative - Signs Broad Teaming Agreement with DynPort Vaccine Company LLC.

March 29, 2004 Vistronix, Inc. and Commonwealth Biotechnologies, Inc. jointly extend contract with Department of the Army to Provide Secure Correspondence Screening Services

March 08, 2004 New Bio-Defense Related Contract Work at Commonwealth Biotechnologies, Inc.

February 04, 2004 Commonwealth Biotechnologies, Inc. Posts Consecutive Profitable Quarters; Closes 2003 with Positive Cash Flow

January 28, 2004 Commonwealth Biotechnologies, Inc. Receives Notice of Allowance for Sepsis Patent

October 16, 2003 Commonwealth Biotechnologies, Inc. Continues to Gain Financial Ground Through 3rd Quarter

September 24, 2003 Commonwealth Biotechnologies, Inc. Signs 3Q Contracts Totaling $2 Million [PDF]

July 22, 2003 Commonwealth Biotechnologies, Inc. Acknowledged by the Department of Defense for Support of the Guard and Reserves [PDF]

July 16, 2003 Commonwealth Biotechnologies, Inc. Receives Notice of Allowance for HIV Patent [PDF]

May 05, 2003 Department of Justice, National Institute of Justice awards Blanket Purchase Agreement to Commonwealth Biotechnologies, Inc. [PDF]

April 15, 2003 Commonwealth Biotechnologies, Inc. Announces Additional Contract Signings For March. New Contract Signings for 1st Quarter 2003 reaches $2.7 Million [PDF]

March 17, 2003 Commonwealth Biotechnologies, Inc. Announces Additional Contract Signings in March, 2003. [PDF]

February 27, 2003 Commonwealth Biotechnologies, Inc. Regains Full Nasdaq Compliance. [PDF]

February 03, 2003 Commonwealth Biotechnologies, Inc. Signs Record Dollar Contracts in January, 2003. Closes 2002 with Major Reductions in Operating Losses, Positive Cash Flow. [PDF]

November 20, 2002 Commonwealth Biotechnologies, Inc. Regains Nasdaq Market Cap Compliance. [PDF]

October 23, 2002 Commonwealth Biotechnologies, Inc. Hires Senior Vice President, Strategic Business Initiatives. [PDF]

October 16, 2002 Commonwealth Biotechnologies, Inc. Continues to Gain Financial Ground Through 3rd Quarter. [PDF]

August 07, 2002 Unaudited Year-to-Date Financial Report for Commonwealth Biotechnologies, Inc. - Positive Trends Reported for EBITDA and Net Loss. [PDF]

May 28, 2002 Commonwealth Biotechnologies, Inc. Signs Peptide Production Contract - Company to provide large amounts of candidate pharmaceutical peptides. [PDF]

May 21, 2002 Commonwealth Biotechnologies, Inc. Signs New Contracts - Company is recognized for its comprehensive research platforms. [PDF]

April 23, 2002 Commonwealth Biotechnologies, Inc. Explores Strategic Options. [PDF]

April 01, 2002 Commonwealth Biotechnologies, Inc. Reports 2001 Financial Outcome. [PDF]

October 16, 2002 Commonwealth Biotechnologies, Inc. and Insmed, Inc. Sign Contract Research Agreement - CBI to support Clinical and Research Related Activities of Insmed. [PDF]